/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-12-16-09-34-16-975-675ff418f1680c6c88e5b5fa.jpg)
Introduction The NIS2 Directive (NIS2 or the Directive) introduces extensive new cybersecurity requirements for a wide range of...
This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
Add a bookmark to get started
Global Site
Back
Cortex - Life Sciences Insights
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/2024-09-09-16-56-46-041-66df28ce097b7a1aca18cbd0.jpg)
Regulatory AIFA updates Guidelines for the classification and conduct of observational studies on medicines On 20 August 2024, the...
/Passle/596df0e43d947619ec025f26/MediaLibrary/Images/5ed622ef8cb62a041c7fddf8/2021-05-17-14-35-11-169-60a27f1fe5416a02a473901a.jpg)
Ethical relations with healthcare professionals are of vital importance for pharmaceutical companies. Cooperation with them results in a...
By
Diego Ramos
Good news at last. Spanish Nurses and Doctors associations have reached a deal, brokered by the Spanish Ministry of Public Health, to...
DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.
© 2024 DLA Piper
Email Disclaimer
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.
